Offer - Urjas Oil for just ₹ 1 X
Uniresp is a commercial drug that is prescribed in the form of Tablet. COPD are some of its major therapeutic uses. Other than this, Uniresp has some other therapeutic uses, which have been discussed ahead.
The optimal dosage of Uniresp is largely dependent on the individual's body weight, medical history, gender and age. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Refer to the dosage section for a detailed discussion.
Besides the aforementioned side effects, there are other adverse effects of Uniresp as well, which are listed below. Such side effects of Uniresp normally do not last long and go away once the treatment is completed. However, if these continue for a longer time, consult your doctor right away.
Uniresp's effect during pregnancy is Severe and Severe while nursing. Further, the section on Uniresp related warnings talks about Uniresp's effects on the liver, heart and kidney.
Uniresp is contraindicated in people with pre-existing medical conditions like Peptic Ulcer as it can result in adverse effects. Some other conditions that can be affected by Uniresp are listed in the contraindications section below.
Besides this, Uniresp may also have severe interaction with some medicines. Refer to the list below for further details.
Along with the above-mentioned precautions, remember that taking Uniresp is considered not safe while driving, and is not addictive.
Uniresp is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
Is the use of Uniresp safe for pregnant women?
Uniresp should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Uniresp safe during breastfeeding?
Women who are breastfeeding may experience severe harmful effects after taking Uniresp. It should only be taken after medical advice.
What is the effect of Uniresp on the Kidneys?
Uniresp rarely affects the kidneys.
What is the effect of Uniresp on the Liver?
You may experience side effects on your liver after taking Uniresp. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Uniresp on the Heart?
Uniresp can have moderate side effects on the heart. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
Uniresp should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Uniresp unless your doctor advises you to do so -
Is this Uniresp habit forming or addictive?
Uniresp is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Uniresp can make you feel drowsy.
Is it safe?
Uniresp should be used only after doctor's advice.
Is it able to treat mental disorders?
No, Uniresp cannot treat any kind of mental disorder.
Interaction between Food and Uniresp
Uniresp may take longer to act if you eat some foods while taking it. Follow your doctor's advice on this.
Interaction between Alcohol and Uniresp
Consult your doctor before consuming alcohol while taking Uniresp as it can have severe side effects.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Theophylline
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 224-227